David Iyú

507 total citations
20 papers, 408 citations indexed

About

David Iyú is a scholar working on Physiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Iyú has authored 20 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Hepatology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Iyú's work include Nitric Oxide and Endothelin Effects (9 papers), Liver Disease and Transplantation (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). David Iyú is often cited by papers focused on Nitric Oxide and Endothelin Effects (9 papers), Liver Disease and Transplantation (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). David Iyú collaborates with scholars based in Spain, United Kingdom and United States. David Iyú's co-authors include Stan Heptinstall, Ann E. White, Andrew J. Johnson, Sue Fox, Susan C. Fox, Noemí M. Atuchá, Joaquín García‐Estañ, M. Clara Ortíz, Subrata Chakrabarti and Jane E. Freedman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

David Iyú

20 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Iyú Spain 12 193 117 71 69 60 20 408
Ferhana Y. Ali United Kingdom 8 224 1.2× 115 1.0× 82 1.2× 224 3.2× 79 1.3× 8 647
Valeria Zuliani Italy 10 111 0.6× 100 0.9× 22 0.3× 45 0.7× 92 1.5× 17 376
Eric G. Spokas United States 11 89 0.5× 95 0.8× 82 1.2× 121 1.8× 134 2.2× 22 550
T Umetsu Japan 10 150 0.8× 81 0.7× 53 0.7× 89 1.3× 16 0.3× 23 436
Clara Santonastaso Italy 11 199 1.0× 83 0.7× 155 2.2× 104 1.5× 79 1.3× 16 646
Takehiro Igawa Japan 10 211 1.1× 75 0.6× 40 0.6× 142 2.1× 20 0.3× 20 562
Dermot Kearney Australia 6 146 0.8× 249 2.1× 14 0.2× 53 0.8× 117 1.9× 11 447
AJ Marcus United States 8 209 1.1× 106 0.9× 191 2.7× 90 1.3× 49 0.8× 11 621
Veronica Boccioletti Italy 11 193 1.0× 14 0.1× 44 0.6× 51 0.7× 42 0.7× 13 426
A R Brash United States 5 108 0.6× 196 1.7× 18 0.3× 51 0.7× 105 1.8× 6 392

Countries citing papers authored by David Iyú

Since Specialization
Citations

This map shows the geographic impact of David Iyú's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Iyú with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Iyú more than expected).

Fields of papers citing papers by David Iyú

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Iyú. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Iyú. The network helps show where David Iyú may publish in the future.

Co-authorship network of co-authors of David Iyú

This figure shows the co-authorship network connecting the top 25 collaborators of David Iyú. A scholar is included among the top collaborators of David Iyú based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Iyú. David Iyú is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romecín, Paola, David Iyú, David García‐Bernal, et al.. (2021). Platelet function and microvesicle generation in patients with hemophilia A. SHILAP Revista de lepidopterología. 9(3). 1408–1415. 2 indexed citations
2.
Iyú, David, Freda Passam, Jack D. Stopa, et al.. (2018). Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation. Journal of Thrombosis and Haemostasis. 16(11). 2322–2335. 35 indexed citations
3.
Romecín, Paola, et al.. (2017). Bile Acids Do Not Contribute to the Altered Calcium Homeostasis of Platelets from Rats with Biliary Cirrhosis. Frontiers in Physiology. 8. 384–384. 1 indexed citations
4.
Romecín, Paola, Noemí M. Atuchá, M. Clara Ortíz, et al.. (2017). Role of homocysteine and folic acid on the altered calcium homeostasis of platelets from rats with biliary cirrhosis. Platelets. 28(7). 698–705. 10 indexed citations
5.
Glenn, Jacqueline R., Ann E. White, David Iyú, & Stan Heptinstall. (2012). PGE2reverses Gs-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-Gs-mediated inhibition of platelet aggregation by interaction with EP4 receptors. Platelets. 23(5). 344–351. 10 indexed citations
6.
Iyú, David, et al.. (2011). P2Y12and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP. Platelets. 22(7). 504–515. 25 indexed citations
7.
Iyú, David, et al.. (2010). PGE1 and PGE2 modify platelet function through different prostanoid receptors. Prostaglandins & Other Lipid Mediators. 94(1-2). 9–16. 52 indexed citations
8.
Iyú, David, et al.. (2010). The role of prostanoid receptors in mediating the effects of PGE2on human platelet function. Platelets. 21(5). 329–342. 51 indexed citations
9.
White, Ann E., et al.. (2010). Mode of action of P2Y12 antagonists as inhibitors of platelet function. Thrombosis and Haemostasis. 105(1). 96–106. 22 indexed citations
10.
Iyú, David, et al.. (2010). Adenosine Derived From ADP Can Contribute to Inhibition of Platelet Aggregation in the Presence of a P2Y 12 Antagonist. Arteriosclerosis Thrombosis and Vascular Biology. 31(2). 416–422. 31 indexed citations
11.
Heptinstall, Stan, David Iyú, Ann E. White, et al.. (2008). DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease. Platelets. 19(8). 605–613. 55 indexed citations
12.
Alcaraz, Antonia, David J. Hernandez, David Iyú, et al.. (2008). Effects of chronic L-NAME on nitrotyrosine expression and renal vascular reactivity in rats with chronic bile-duct ligation. Clinical Science. 115(2). 57–68. 8 indexed citations
13.
Atuchá, Noemí M., David Iyú, Antonia Alcaraz, et al.. (2007). Altered calcium signalling in platelets from bile-duct-ligated rats. Clinical Science. 112(3). 167–174. 11 indexed citations
14.
Iyú, David, et al.. (2006). Vitamin E supplementation reverses renal altered vascular reactivity in chronic bile duct-ligated rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 292(4). R1486–R1493. 6 indexed citations
15.
Atuchá, Noemí M., David Iyú, Antonia Alcaraz, et al.. (2005). Role of Vascular Nitric Oxide in Experimental Liver Cirrhosis. Current Vascular Pharmacology. 3(1). 81–85. 12 indexed citations
16.
Atuchá, Noemí M., et al.. (2005). Reduced capacitative calcium entry in the mesenteric vascular bed of bile duct-ligated rats. European Journal of Pharmacology. 525(1-3). 117–122. 3 indexed citations
17.
Chakrabarti, Subrata, Olga Vitseva, David Iyú, Sonia Varghese, & Jane E. Freedman. (2005). The Effect of Dipyridamole on Vascular Cell-Derived Reactive Oxygen Species. Journal of Pharmacology and Experimental Therapeutics. 315(2). 494–500. 42 indexed citations
18.
Iyú, David, et al.. (2004). Altered calcium signaling in platelets from nitric oxide-deficient hypertensive rats. Cell Communication and Signaling. 2(1). 1–1. 18 indexed citations
19.
Atuchá, Noemí M., et al.. (2002). Interaction of nitric oxide with calcium in the mesenteric bed of bile duct‐ligated rats. British Journal of Pharmacology. 135(2). 489–495. 11 indexed citations
20.
Atuchá, Noemí M., et al.. (2002). [Role of vascular nitric oxide in experimental liver cirrhosis].. PubMed. 22 Suppl 5. 25–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ferhana Y. Ali Breakdown of academic impact, for papers by Valeria Zuliani Breakdown of academic impact, for papers by Eric G. Spokas Breakdown of academic impact, for papers by T Umetsu Breakdown of academic impact, for papers by Clara Santonastaso Breakdown of academic impact, for papers by Takehiro Igawa Breakdown of academic impact, for papers by Dermot Kearney Breakdown of academic impact, for papers by AJ Marcus Breakdown of academic impact, for papers by Veronica Boccioletti Breakdown of academic impact, for papers by A R Brash
Rankless by CCL
2026